Streetbeat News

Regulatory

SPY

In a Bloomberg TV interview, Fed's Goolsbee stated that the Federal Reserve is not yet at the point of determining the neutral rate and has time to decide on the policy rate's settling point.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:13 pm

SPY

In a Bloomberg TV interview, Fed's Goolsbee indicated that there are signs inflation might undershoot the target, suggesting the need to maintain current economic conditions.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:09 pm

SPY

In a Bloomberg TV interview, Fed's Goolsbee highlighted that most Fed policymakers anticipate a significant reduction in interest rates over the next 12 to 18 months. He cautioned against maintaining overly restrictive rates.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:08 pm

EXAS

GH

The FDA has approved Exact Sciences Corp.'s Cologuard Plus test, a next-generation colorectal cancer diagnostic for adults 45 and older. The test showed high sensitivity and specificity in the pivotal BLUE-C study. It will launch in 2025 and is expected to be covered by Medicare. Exact Sciences' stock rose 1.94% following the news.

Portfolio Pulse from Vandana Singh

October 04, 2024 | 1:41 pm

VMAR

Vision Marine Technologies has been granted an extension to remain listed on Nasdaq and will implement a 1-for-9 reverse stock split to meet compliance requirements.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:33 pm

TPX

Tempur Sealy International, Inc. has filed a complaint seeking to enjoin the FTC's administrative challenge to its merger with Mattress Firm, arguing it violates constitutional protections. A federal court hearing is scheduled for November 12, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:31 pm

MDT

Medtronic has initiated a recall of its MiniMed insulin pumps due to battery life concerns, which could lead to serious health risks. The FDA has classified this as a class I recall, the most serious type. Medtronic advises users to monitor battery alerts closely and carry extra batteries.

Portfolio Pulse from Vandana Singh

October 04, 2024 | 1:21 pm

SPY

Federal Reserve's John Williams did not provide any comments on monetary policy or the economic outlook during his prepared remarks at a recent conference.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:09 pm

JNJ

Johnson & Johnson has decided to discontinue its Phase 2 field study on an investigational antiviral for dengue prevention. This decision is part of a strategic reprioritization of the company's communicable diseases R&D portfolio. No safety issues have been identified in the study so far.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:04 pm

ALSA

Alpha Star Acquisition has received a notice from Nasdaq regarding a deficiency in meeting the minimum market value requirement. This could impact the company's stock listing status.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:02 pm